Perinatal group B streptococcal disease

Area of Science:

• Obstetrics and Gynecology
• Neonatal Medicine
• Infectious Diseases

Background:

• Group B Streptococcus (GBS) is a primary cause of neonatal sepsis and meningitis.
• Despite treatment, GBS infections lead to significant infant morbidity and mortality.
• Effective prevention strategies are essential to reduce GBS-related adverse outcomes.

Purpose of the Study:

• To review prevention strategies for neonatal Group B Streptococcus infections.
• To highlight the importance of timely antibiotic administration in preventing early-onset GBS disease.
• To compare risk-factor-based versus swab-based screening for GBS.

Main Methods:

• Review of current obstetric and midwifery practices for GBS prevention.
• Analysis of two primary GBS screening strategies: clinical risk factors and late-pregnancy vaginal/rectal swabs.
• Discussion of the efficacy and implications of each prevention approach.

Main Results:

• Antibiotic administration prior to delivery is key to preventing early-onset GBS disease.
• Two main strategies exist for identifying at-risk pregnancies: clinical risk factors or GBS screening via swabs.
• Swab-based screening demonstrates higher efficacy but may increase antibiotic exposure.

Conclusions:

• Prevention of neonatal GBS disease relies heavily on obstetricians and midwives.
• The choice between risk-factor and swab-based strategies involves balancing efficacy with antibiotic stewardship.
• Optimizing GBS prevention requires careful consideration of available screening methods.